Treatment of vertical bone defects with Class IV recession before prosthetic treatment in a patient with chronic periodontitis

Janina Czuryszkiewicz-Cyrana, Aleksandra Bączkiewicz, Renata Samulak-Zielińska, Elżbieta Dembowska

Streszczenie

Białka matrycy szkliwa zawarte w preparacie Emdogain® znajdują szerokie zastosowanie w chirurgii periodontologicznej ze względu na swoje właściwości regenerujące. Są wykorzystywane w chirurgicznych zabiegach periodontologicznych zarówno do zwiększenia efektywności leczenia ubytków kostnych, jak i w pokrywaniu recesji w połączeniu z różnymi technikami chirurgicznymi. Aplikuje się go samodzielnie, a także w połączeniu z innymi biomateriałami. Celem pracy jest przedstawienie przypadku własnego leczonego z zastosowaniem białek matrycy szkliwa oraz przeszczepu tkanki łącznej podnabłonkowej. Stanowią one materiał bezpieczny, dobrze tolerowany przez tkanki, niewywołujący powikłań pozabiegowych ani działań niepożądanych.

Abstract

Enamel matrix proteins contained in the preparationEmdogain® (EMD) are widely used in periodontal surgery because of its significant regenerative properties. EMD is used both for improving efficiency of the treatment of intrabony defects and for treatment of gingival recessions with various surgical techniques. It is possible to apply EMD alone as well as in combination with other biomaterials. The aim of the study was to review the literature and to present the authors’ own case of treatment with EMD and connective tissue graft (CTG). EMD consists of enamel matrix derivative. It is used in assisting and shortening the time taken for soft and hard tissues healing. EMD is safe, well tolerated by tissues and does not create postoperative complications or any untoward effects.

Hasła indeksowe: białka matrycy szkliwa, pionowe ubytki kostne, sterowana regeneracja tkanek, przeszczep podnabłonkowej tkanki łącznej

Key words: enamel matrix derivative, periodontal intraosseous defects, guided tissue regeneration, subepithelial connective tissue graft

PIŚMIENNICTWO

1. Bhutda G., Deo .V: Five years clinical results following treatment of human intra-bony defects with an enamel matrix derivative: a randomized controled trial. Acta Odontol. Scand., 2013, 71, 764-770.

2. Sculean A. i wsp.:  Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration. J. Clin. Periodontol., 2008, 35, 817-824.

3. Parashis A.O. i wsp.: Enamel matrix derivative in intrabony defects. Prognostic parameters of clinical and radiographic treatment outcomes. J. Periodontol., 2012, 83, 11, 1346-1352.

4. Miron R.J. i wsp.: 20 years of Enamel Matrix Derivative: the past, the present and future. J. Clin. Periodontol., 2016 Mar 14,  doi: 10.1111/jcpe.12546. [Epub ahead of print].

5. Miller P.D. Jr: A classification of marginal tissue recession. Int. J. Periodontics Restorative Dent., 1985, 5, 8-13.

6. Hürzeler M.B., Weng D.: A single-incision technique to harvest subepithelial connective tissue grafts from the palate. Int. J. Periodontics Restorative Dent., 1999, 19, 3, 279-287.

7. Chambrone L., Tatakis D.N.: Periodontal soft tissue root coverage procedures: a systematic review from the AAP Regeneration Workshop. J. Periodontol., 2015,  86, 2 Suppl., 8-51.

8. Zucchelli G. i wsp.: Nowa technika przeszczepu tkanki łącznej w celu poprawy pokrycia korzenia i poziomu przyczepu łącznotkankowego w recesji dziąsłowej klasy IV wg Millera. Quintessence Periodontologia Implanty, 2014, 13, 246-257.

9. Henriques P. i wsp.:  Application of subepithelial connective tissue graft with or without enamel matrix derivative for root coverage: a split-mouth randomized study. J. Oral Sci., 2010, 52, 3, 463-471.

10. Cheng G.L. i wsp.: Root coverage by coronally advanced flap with connective tissue graft and/or enamel matrix derivative: a meta-analysis. J. Periodont. Res., 2015, 50, 2, 220-230.

11. Miron R..J, Dard M., Weinreb M.: Enamel matrix derivative, inflammation and soft tissue wound healing. J. Periodontal Res., 2015, 50, 5, 555-569.

12. Yilmaz S, . i wsp.: Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone. J. Clin. Periodontol., 2010, 37, 544-550.

13. Trombelli L. i wsp.: Autogenous bone graft in conjunction with enamel matrix derivative in the treatment of deep periodontal intra-osseous defects: a report of 13 consecutively treated patients. J. Clin. Periodontol., 2006, 33, 69-75.

14. Siciliano V.I. i wsp.: Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial. J. Periodontol., 2011, 82, 62-71.

15. De Leonardis D., Paolantonio M.: Enamel matrix derivative, alone or associated with a synthetic bone substitute, in the treatment of 1- to 2-wall periodontal defects. J. Periodontol., 2013, 84, 444-455.

16. Jentsch H., Purschwitz R.: A clinical study evaluating the treatment of supra-alveolar-type defects with access flap surgery with and without an enamel matrix protein derivative: a pilot study. J. Clin. Periodontol., 2008, 35, 713-718.

17. Fickl S. i wsp.:  Microsurgical access flap in conjunction with enamel matrix derivative for the treatment of intra-bony defects: a controlled clinical trial. J. Clin. Periodontol., 2009, 36, 784-790.

18. Heden G., Wennström J.L.: Five-year follow-up of regenerative periodontal therapy with enamel matrix derivative at sites with angular bone defects. J. Periodontol., 2006, 77, 295-301.

19. Sculean A. i wsp.:  Treatment of intrabony defects with an enamel matrix protein derivative or bioabsorbable membrane: an 8-year follow-up split mouth study. J. Periodontol., 2006,  77, 1879-1886.

20. Sculean A. i wsp.: Nine-year results following treatment of intrabony periodontal defects with an enamel matrix derivative: report of 26 cases. Int. J. Periodontics Restorative Dent., 2007, 27, 221-229.

21. Döri F. i wsp.: Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a b-Tricalcium phosphate. J. Periodontol., 2013, 84, 749-757.

22. Sculean A. i wsp.: Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral. Int. J. Periodontics Restorative Dent., 2008, 28, 153-161.

23. Konopka T: Przygotowanie pacjentów z przewlekłym zapaleniem przyzębia do leczenia protetycznego. e-Dentico, 2011, 4, 32, 8-26.

24. Pietruski J.K., Pietruska M.D.: Stałe uzupełnienia protetyczne u pacjentów z periodontopatiami. e-Dentico, 2011, 4, 32, 54-66.

25.  Cairo F., Nieri M., Pagliaro U.: Efficacy of periodontal plastic surgery procedures in the treatment of localized gingival recessions. A systematic review. J. Clin. Periodontol., 2014, 41, Suppl. 15, 44-62.